Document is current
Any future updates will be listed below
-
Authors
Gangiah, Tamlyn K.
Alisoltani, Arghavan
Potgieter, Matthys
Bell, Liam
Ross, Elizabeth
Iranzadeh, Arash
McDonald, Zac
Allali, Imane
Dabee, Smritee
Barnabas, Shaun
Blackburn, Jonathan M.
Tabb, David L.
Bekker, Linda-Gail
Jaspan, Heather B.
Passmore, Jo-Ann S.
Mulder, Nicola
Masson, Lindi
-
Funding
Funding for this research was provided by:
Carnegie Corporation of New York
South African National Research Foundation
South African Medical Research Council
South African Department of Science and Technology
European and Developing Countries Clinical Trials Partnership Strategic Primer (SP.2011.41304.038)
Australian National Health and Medical Research Council
- License Information
-
More Information
Article History
Received: 4 September 2023
Accepted: 11 February 2025
First Online: 19 March 2025
Declarations
:
: The University of Cape Town Faculty of Health Sciences Human Research Ethics Committee (HREC REF: 267/2013) approved this study. Women ≥ 18 years provided written informed consent, those < 18 years provided informed assent, and informed consent was obtained from parents/guardians.
: Not applicable.
: The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE [1] partner repository with the dataset identifier PXD046053.
: The authors declare no competing interests.
